Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.
The FDA has approved Enbumyst offering a self-administered outpatient option for managing edema in patients with heart failure, liver disease, and kidney disease.
Antiviral therapy lowers taurochenodeoxycholic acid concentrations in patients with hepatitis B virus cirrhosis, reflecting changes in bile acid balance with viral suppression.